Arunima Silsarma
Overview
Explore the profile of Arunima Silsarma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
0
Followers
0
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singla R, Khan S, Silsarma A, Chavan V, Mahajan R, Mansoor H, et al.
Clin Infect Dis
. 2025 Mar;
PMID: 40079698
Background: Bedaquiline (BDQ) resistance presents a critical challenge in the fight against tuberculosis (TB), particularly multidrug-resistant (MDR) strains. The emergence of resistance to BDQ, a key drug in treating MDR-TB,...
2.
Khan S, Silsarma A, Mahajan R, Khan S, Davuluri P, Sutar N, et al.
J Clin Tuberc Other Mycobact Dis
. 2024 Nov;
37:100481.
PMID: 39497757
Background: Tuberculosis (TB) remains a significant cause of mortality globally, with India accounting for 27% of the estimated number of people with TB. Multidrug-resistant TB (MDR-TB) and isoniazid (INH) resistance...
3.
Mongia H, Mamnoon F, Silsarma A, Mahajan R, Dalal A, Galindo M, et al.
J Clin Tuberc Other Mycobact Dis
. 2024 Apr;
35:100433.
PMID: 38617837
Background: World Health Organization suggests concurrent bedaquiline-delamanid (BDQ-DLM) as part of individualised regimens for eligible patients with pulmonary drug-resistant tuberculosis (DR-TB); however, data for patients with drug-resistant extrapulmonary tuberculosis (EPTB)...